Targeting the endo-lysosomal autophagy pathway to treat inflammatory bowel diseases
Sruthi Vijaya Retnakumar(Centre National de la Recherche Scientifique), Sylviane Muller(Centre National de la Recherche Scientifique)
Cited by 23
Related Papers
Lysosomes as a therapeutic target
|Nature Reviews Drug Discovery|2019|751
OX40 Ligand Contributes to Human Lupus Pathogenesis by Promoting T Follicular Helper Response
|Immunity|2015|223
Progress and Challenges in the Use of MAP1LC3 as a Legitimate Marker for Measuring Dynamic Autophagy In Vivo
|Cells|2020|44
Novel trisaccharide based phospholipids as immunomodulators
|International Immunopharmacology|2019|14